Patents by Inventor Patrick Heiser

Patrick Heiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING INFERTILITY
    Publication number: 20240009278
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: May 5, 2023
    Publication date: January 11, 2024
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE, Jane RUMAN, Patrick HEISER
  • HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT WITH POLYCYSTIC OVARY SYNDROME
    Publication number: 20230248807
    Abstract: Described are assisted reproductive technology compositions and methods using highly purified menotropin (HP-hMG) to stimulate follicle development, particularly in women who have been diagnosed with oligoovulation and/or PCOS and who are predicted to have a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: June 26, 2020
    Publication date: August 10, 2023
    Applicant: Ferring B.V.
    Inventor: Patrick HEISER
  • COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING INFERTILITY
    Publication number: 20230210955
    Abstract: The present invention relates to improved assisted reproductive technology for women predicted to have a high ovarian response to controlled ovarian stimulation that comprise targeting a threshold serum hCG level by the final day of stimulation.
    Type: Application
    Filed: May 28, 2021
    Publication date: July 6, 2023
    Applicant: FERRING B.V.
    Inventors: Patrick HEISER, Eric FOSTER
  • Methods of treating infertility
    Patent number: 11679145
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: June 20, 2023
    Assignee: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman, Patrick Heiser
  • COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION
    Publication number: 20210353717
    Abstract: Methods using and compositions including FSH for use in the treatment of infertility are described, wherein the dose is selected based on the patient's age to optimise cumulative efficiency and/or reduce OHSS risk.
    Type: Application
    Filed: October 17, 2019
    Publication date: November 18, 2021
    Applicant: FERRING B.V.
    Inventors: Joan-Carles ARCE SAEZ, Lisbeth HELMGAARD, Bjarke Mirner KLEIN, Patrick HEISER
  • METHODS OF TREATING INFERTILITY
    Publication number: 20210093697
    Abstract: The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
    Type: Application
    Filed: December 10, 2020
    Publication date: April 1, 2021
    Applicant: FERRING B.V.
    Inventors: Joan-Carles Arce, Jane Ruman, Patrick Heiser